- Home
- CPIX vs BYSI Comparison
CPIX vs BYSI Comparison
Compare CPIX & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPIX
- BYSI
- Stock Information
- Founded
- CPIX 1999
- BYSI 2010
- Country
- CPIX United States
- BYSI United States
- Employees
- CPIX N/A
- BYSI N/A
- Industry
- CPIX Biotechnology: Pharmaceutical Preparations
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- CPIX Health Care
- BYSI Health Care
- Exchange
- CPIX Nasdaq
- BYSI Nasdaq
- Market Cap
- CPIX 68.7M
- BYSI 72.1M
- IPO Year
- CPIX 2009
- BYSI 2017
- Fundamental
- Price
- CPIX $4.76
- BYSI $1.31
- Analyst Decision
- CPIX
- BYSI
- Analyst Count
- CPIX 0
- BYSI 0
- Target Price
- CPIX N/A
- BYSI N/A
- AVG Volume (30 Days)
- CPIX 43.3K
- BYSI 24.5K
- Earning Date
- CPIX 05-06-2025
- BYSI 01-01-0001
- Dividend Yield
- CPIX N/A
- BYSI N/A
- EPS Growth
- CPIX N/A
- BYSI N/A
- EPS
- CPIX N/A
- BYSI N/A
- Revenue
- CPIX $37,867,945.00
- BYSI N/A
- Revenue This Year
- CPIX N/A
- BYSI N/A
- Revenue Next Year
- CPIX N/A
- BYSI N/A
- P/E Ratio
- CPIX N/A
- BYSI N/A
- Revenue Growth
- CPIX N/A
- BYSI N/A
- 52 Week Low
- CPIX $1.04
- BYSI $0.98
- 52 Week High
- CPIX $7.25
- BYSI $3.63
- Technical
- Relative Strength Index (RSI)
- CPIX 56.04
- BYSI 44.17
- Support Level
- CPIX $3.98
- BYSI $1.03
- Resistance Level
- CPIX $4.41
- BYSI $1.27
- Average True Range (ATR)
- CPIX 0.30
- BYSI 0.15
- MACD
- CPIX 0.06
- BYSI 0.00
- Stochastic Oscillator
- CPIX 98.00
- BYSI 48.53
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.